MyFinsight
Home
Blog
About
Marketable securities
$816,544K
(83.07%↑ Y/Y)
Cash and cash
equivalents
$164,986K
(40.62%↑ Y/Y)
Other receivable
$75,000K
Prepaid expenses and
other current assets
$24,740K
(60.71%↑ Y/Y)
Total current assets
$1,081,270K
(86.83%↑ Y/Y)
Intangible asset, net
$10,000K
Property and equipment,
net
$2,765K
(153.44%↑ Y/Y)
Operating lease
right-of-use asset
$2,085K
(5.46%↑ Y/Y)
Other assets
$1,113K
(119.96%↑ Y/Y)
Total assets
$1,097,233K
(88.42%↑ Y/Y)
Total liabilities and
stockholders equity
$1,097,233K
(88.42%↑ Y/Y)
Total stockholders
equity
$662,097K
(28.52%↑ Y/Y)
Total liabilities
$435,136K
(547.96%↑ Y/Y)
Accumulated deficit
-$1,570,478K
(-32.70%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$1,153K
(-1771.01%↓ Y/Y)
Additional paid-in capital
$2,134,572K
(41.47%↑ Y/Y)
Convertible notes, net
$242,159K
Liability related to the
sale of future...
$113,642K
Total current
liabilities
$63,794K
(21.32%↑ Y/Y)
Derivative liability
$13,690K
Other liabilities
$1,851K
(-10.88%↓ Y/Y)
Preferred stock-Series
APreferred Stock
$60,432K
(-1.24%↓ Y/Y)
Preferred stock-Series
BPreferred Stock
$37,592K
(-70.56%↓ Y/Y)
Common stock, 0.01 par
value 200,000,000...
$1,132K
(38.56%↑ Y/Y)
Accrued liabilities
$55,142K
(56.02%↑ Y/Y)
Accounts payable
$8,652K
(1.57%↑ Y/Y)
Back
Back
Balance Sheet
Viridian Therapeutics, Inc. DE (VRDN)
Viridian Therapeutics, Inc. DE (VRDN)
source: myfinsight.com